Tekmira Pharma (TKMR) Reports Q3 Loss of 39c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Form 8-K TEKMIRA PHARMACEUTICALS For: Nov 06
November 6, 2014 3:31 PM ESTUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 6, 2014
Tekmira Pharmaceuticals Corporation
(Exact name of registrant as specified in its charter)... More
Form 8-K TEKMIRA PHARMACEUTICALS For: Nov 05
November 6, 2014 6:04 AM ESTUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 5, 2014
Tekmira Pharmaceuticals Corporation
(Exact name of registrant as specified in its charter)... More
